Skip to main content
Biomunex Pharmaceuticals
Menu
  • Company

    © 2026 Biomunex Pharmaceuticals

    About Biomunex
    Team
    Strategic & Scientific Advisory Board
    LinkedIn

  • Science

    © 2026 Biomunex Pharmaceuticals

    Bispecific & Multi-Specific Antibodies
    BiXAb® Platform Technologies
    MAIT Engagers
    Products & Pipeline
    Intellectual Property
    LinkedIn

  • Partnering

    © 2026 Biomunex Pharmaceuticals

    Academic & Institutional Collaborations
    Industrial Partnership Agreements
    Development & Licence Agreements
    LinkedIn

  • News
  • Contact Us
Biomunex Pharmaceuticals

Breakthrough Antibody-Based Therapies in Immuno-Oncology.

Company

About Us
Team
Strategic & Scientific Advisory Board

Science

Bispecific & Multi-Specific Antibodies
BiXAb® Platform Technologies
MAIT Engagers
Products & Pipeline
Intellectual Property

Partnering

Academic & Institutional Collaborations
Industrial Partnership Agreements
Development & Licence Agreements

Ressources

News
Contact Us
@2026

Biomunex Pharmaceuticals

Legal notice
Privacy Policy
Website by ScreenUp
Close Menu
  • Company
    • About Biomunex
    • Team
    • Strategic & Scientific Advisory Board
  • Science
    • Bispecific & Multi-Specific Antibodies
    • BiXAb® Technology
    • MAIT Engagers
    • Intellectual Property
    • Products & Pipeline
  • Partnering
    • Academic & Institutional Collaborations
    • Industrial Partnership Agreements
    • Development & Licence Agreements
  • News
  • Contact Us